| Accession Number | 0001205703-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 21, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Global Head of R&D | Common Stock | โ | Apr 17, 2026 | Exercise/Conversion | 6,077 | $64.25 | $390,447.25 | 268,769 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Apr 17, 2026 | Exercise/Conversion | 12,590 | $71.93 | $905,598.70 | 281,359 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Apr 17, 2026 | Sale | 18,667 | $96.50 | $1,801,365.50 | 262,692 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Apr 17, 2026 | Exercise/Conversion | 6,077 | $0.00 | $0.00 | 26,833 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Apr 17, 2026 | Exercise/Conversion | 12,590 | $0.00 | $0.00 | 27,699 | Direct | โ | View Details |